Jeff Spigel

is a partner in King & Spalding’s Washington, D.C., office where he is head of the Antitrust Practice Group. Mr. Spigel’s practice focuses on advising clients with responding to civil and criminal antitrust investigations in the United States and abroad, obtaining Hart-Scott-Rodino clearance and coordinating approvals in foreign jurisdictions of proposed transactions, pursuing or defending against antitrust claims, and counseling on strategic antitrust issues such as those arising from benchmarking, competitor collaborations, distribution, licensing, marketing, pricing, and trade association participation. Mr. Spigel also has significant antitrust experience in various segments of the healthcare industry. He frequently advises healthcare clients on strategic transactions, messenger model networks, financially and/or clinically integrated networks, Group Purchasing Organizations and claims by commercial payors, competitors, or the government. Mr. Spigel’s antitrust experience also includes advising clients in a broad range of industries, including building materials, chemicals, energy, financial, metals, paper, pharmaceutical, retail, telecommunications, and the Internet.

Mr. Spigel appears regularly before the U.S. Department of Justice and the Federal Trade Commission, and he coordinates with foreign counsel in dealing with competition authorities in jurisdictions around the globe. In addition, Mr. Spigel represent clients on unfair and deceptive trade practice matters before the Federal Trade Commission, Consumer Financial Protection Bureau, and State Attorneys General.

Legal 500 and Super Lawyers have identified him as a leading antitrust lawyer. In addition, Nightingale Healthcare News has named him one of the “Outstanding Healthcare Antitrust Lawyers” in the United States.

A graduate of Emory University, Mr. Spigel received his J.D. from the University of Miami School of Law and an L.L.M. in Taxation from Georgetown University Law Center. He is a member of the District of Columbia Bar and State Bar of Tennessee. Mr. Spigel is also a member of the Antitrust Section of the American Bar Association, the American Health Lawyers Association, the Federal Communications Bar Association and the International Bar Association.

Publications

“The Costs Of A Potential Blue Cross Conspiracy,” Law 360 (May 2012)

“Inside The CFPB Proposed Rules For Mortgage Servicers,” Law 360 (May 2012)

“The Latest FTC Challenge To A Hospital Merger,” Law 360 (April 2012)

“Targeting Health Care Antitrust In Texas,” Law 360 (March 2011)

“DOJ's Double Trouble,” Law 360 (June 2011)

Co-author of treatise chapter on “Antitrust Issues” in: Varner & Bayman, Regulation of Pharmaceutical Manufacturers (Law Journal Press 2011).

Presentations

“Recent Healthcare Antitrust Developments,” The Health Law and Policy Forum, King & Spalding, Atlanta, March 2013

“Washington Insight: Getting to know the Consumer Financial Protection Bureau,” Jeffrey S. Spigel, King & Spalding, J.C. Boggs, King & Spalding, Tish McDonald, King & Spalding, Scott Stengel, King & Spalding, Patryk Drescher, Director, Regulatory Services, U.S. Bancorp, Len Kennedy, Senior Advisor and Counselor, Consumer Financial Protection Bureau, Mark Metz, Deputy General Counsel, Bank of America, & Jess Sharp, Executive Director, U.S. Chamber’s Center for Capital Markets, King & Spalding, Washington, D.C., October 2012

“Antitrust under the Obama Administration, DOJ, FTC, Texas AG and Private Practitioners’ Perspectives,” Jeffrey S. Spigel, King & Spalding, Jeff Perry, Assistant Director of the Bureau of Competition, Mergers IV, Federal Trade Commission, William H. Stallings, Chief, Transportation, Energy & Agriculture Section, U.S. Department of Justice Antitrust Division, & Kim Van Winkle, Chief, Antitrust Section, Texas Attorney General’s Office, King & Spalding and the State Bar of Texas, Antitrust and Business Litigation Section, Austin, September 2012

“2012 Managed Care Update," King & Spalding, Atlanta, June 2012

“Accountable Care Organizations and Antitrust,” The Health Law and Policy Forum, King & Spalding, Atlanta, March 2011